Patient Blood Management Guidlines Development Banner

Progress Updates


November/December 2011


The Review of the NHMRC/ASBT Clinical Practice Guidelines on Fresh Blood Components (2001) will result in the production of six modules as part of a comprehensive, evidence-based, Patient Blood Management Guideline. The modules are being produced in three phases as follows:


Phase 1:
Critical Bleeding/Massive Transfusion
Peri-operative
Phase 2:
Medical
Critical Care
Phase 3:
Obstetrics
Paediatrics & Neonates


Phase 1


Module 1 - Critical Bleeding/Massive Transfusion After undergoing public consultation, peer review and an independent AGREE II assessment the Critical Bleeding/Massive Transfusion module was approved by NHMRC last year. The module, the accompanying “quick reference guide” and a template massive transfusion protocol can be ordered or downloaded from this website.


Module 2 - Peri-operative This module was approved by NHMRC on 15th November, 2011 and is expected to be available to order or download via the NBA website in early 2012.



Phase 2


Medical - The Medical Clinical/Consumer Reference Group is finalising the clinical guidance chapter and seeking specialist advice on specific sections of the module. A meeting was held on 17th and 18th November and sign off of the draft is expected in December, allowing for public consultation to begin in late January 2012.


Critical Care - The Critical Care Clinical/Consumer Reference Group met on 28th November to consider the results of the systematic review for Generic Question 2. The group will meet in February to review the recommendations and practice points, clinical guidance chapter and finalise the module ready for public consultation in mid-2012.

Phase 3


Membership of the Clinical/Consumer Reference Group for the Obstetric module and Paediatrics & Neonates module is still being considered and the group is expected to meet in early 2012.



For further information please contact the NBA at guidelines@nba.gov.au or register on this website to automatically receive these updates.

 

 

Feedback | Privacy | Copyright | Disclaimer | Contact Us

This page last modified on December 9, 2011
ABN 87 361 602 478 © Commonwealth of Australia 2010

BloodNet


Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg)


RFT 01/2012 - Review of the authorisation and clinical governance framework for intravenous immunoglobulin


AHMC Stewardship Statement


Patient Blood Management


Blood Supply to Australians Oversea


New supply arrangements for IVIg


Donate Blood